SEC Form 4 · accession 0001772652-26-000006
NEUROONE MEDICAL TECHNOLOGIES Corp · NMTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Mertens
Officer — Chief Technology Officer
Period of report
Aug 28, 2026
Accepted (ET)
Aug 28, 2026 · 4:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001500198
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $1.77 | Aug 28, 2026 | A | 15,000 | A | — | Aug 27, 2036 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F125% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.